Natixis Advisors LLC boosted its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 6.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 28,346 shares of the real estate investment trust’s stock after purchasing an additional 1,739 shares during the period. Natixis Advisors LLC’s holdings in Sabra Health Care REIT were worth $528,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Family Firm Inc. acquired a new stake in Sabra Health Care REIT in the second quarter worth approximately $26,000. Assetmark Inc. lifted its position in Sabra Health Care REIT by 168.4% in the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 1,231 shares during the period. GAMMA Investing LLC lifted its position in Sabra Health Care REIT by 40.0% in the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust’s stock worth $57,000 after purchasing an additional 1,052 shares during the period. Harbor Capital Advisors Inc. acquired a new stake in Sabra Health Care REIT in the third quarter worth approximately $78,000. Finally, International Assets Investment Management LLC lifted its position in Sabra Health Care REIT by 1,761.0% in the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 5,776 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
SBRA has been the subject of a number of research analyst reports. Scotiabank upped their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Friday, October 11th. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $17.00 to $20.00 in a research note on Friday, September 13th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Truist Financial raised their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and an average target price of $18.71.
Sabra Health Care REIT Stock Performance
SBRA opened at $18.91 on Friday. The firm has a market cap of $4.47 billion, a PE ratio of 46.12, a P/E/G ratio of 2.33 and a beta of 1.25. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. The business has a fifty day simple moving average of $18.63 and a 200-day simple moving average of $16.78. Sabra Health Care REIT, Inc. has a fifty-two week low of $12.83 and a fifty-two week high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last issued its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). The business had revenue of $178.00 million during the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period last year, the business earned $0.34 EPS. As a group, equities analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.35%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.69%.
Sabra Health Care REIT Profile
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Read More
- Five stocks we like better than Sabra Health Care REIT
- The Significance of Brokerage Rankings in Stock Selection
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- When to Sell a Stock for Profit or Loss
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Using the MarketBeat Stock Split Calculator
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.